Moova Condroguard 120 Tablets

Moova Condroguard 120 Tablets is a supplement specifically formulated for the joint well-being of dogs. Its tablets to be administered daily represent a valid support for maintaining the physiological functionality of the joints, especially in the most active subjects, in sporting dogs and in elderly animals, which may show reduced joint mobility or signs of discomfort related to age and cartilaginous degeneration. Moova Condroguard, thanks to its rich and balanced formulation, can be used in prevention or as a complement in protocols to support normal musculoskeletal and joint structure health, providing a constant supply of substances selected for their effectiveness.

Intake is simple, thanks to a palatability specifically designed to facilitate spontaneous acceptance of the tablet even in the most demanding dogs or in those that normally refuse the usual oral supplementation. It can be administered either directly into the mouth or mixed with food, without altering the taste or smell of the usual meal. The 120 tablet format is practical and ideal for long-term cycles or for families with multiple animals, offering a convenient and effective solution for prolonged supplementation needs.

Therapeutic Indications

Moova Condroguard is indicated for the maintenance and recovery of joint function in dogs of all breeds and sizes. It exerts a specific supporting action in subjects suffering from arthrosis, in dogs undergoing orthopedic operations, in periods of post-traumatic or post-surgical convalescence, as well as in animals in which it is necessary to prevent possible joint problems linked to genetic predispositions, obesity or intense physical activity. The product proves to be particularly useful for slowing down the degenerative processes typical of advanced age, counteracting the loss of elasticity, morning stiffness, difficulty climbing stairs or carrying out movements that impact the joints.

Regular administration promotes a better response to joint stress, helps maintain muscle tone, facilitates the dog's vitality and quality of life, allowing for smoother walking and correct posture. The product is often recommended by veterinarians also in association with anti-inflammatory therapies, physiotherapy and joint rehabilitation programs, supporting the restoration of locomotor well-being. Thanks to its safety of use, it is also suitable for long-term integrations, providing constant and continuous support over time.

Composition

Active ingredients: The heart of the Moova Condroguard formulation lies in a synergistic blend of natural substances selected to promote joint health. Among the main ingredients we find Glucosamine, Chondroitin, MSM (methylsulfonylmethane), extracts of plants such as Boswellia and Devil's Claw, substances known for their protective and supportive action in the renewal processes of the articular cartilage. Glucosamine and Chondroitin promote the production of cartilaginous components and the preservation of joint lubrication, while MSM provides organic sulfur, fundamental for regenerative and anti-inflammatory processes.

The presence of vitamins (for example vitamin C and E) and minerals such as manganese supports antioxidant processes, protecting cells and tissues from oxidative stress. The excipients present have been chosen to optimize the digestibility and palatability of the tablets: there are hydrolysed meat flour, corn starch and processed plant derivatives to minimize the presence of common allergens and facilitate gastrointestinal tolerability even in the most sensitive subjects.

Contraindications

Moova Condroguard 120 Tablets must not be used in dogs with known or suspected hypersensitivity to any of the components of the formulation, especially in cases of clear allergy to animal or vegetable protein sources included among the excipients. The product is not intended for use in puppies under three months of age or in severely debilitated subjects without veterinary supervision. Administration is not recommended in animals with severe renal or hepatic insufficiency unless expressly indicated by the veterinarian, as the filtering activity of the organs could already be compromised and the absorption of the ingredients could be negatively affected.

Do not use in conjunction with other supplements containing significant quantities of MSM, Glucosamine or Chondroitin, to avoid risks of overdose. In case of doubts or the appearance of unexpected side effects after administration (itching, vomiting, prolonged diarrhea or other gastrointestinal disorders), discontinue use and consult your veterinarian.

Safety of the drug for the species

The supplement has been specifically tested on dogs belonging to different breeds and sizes, with a high safety profile also confirmed by prolonged use. The synergistic association of natural active ingredients allows the use of Moova Condroguard in total safety, also allowing long-lasting treatments without significant documented adverse effects. Clinical studies and veterinary testimonials confirm its tolerability profile even in elderly dogs or those undergoing rehabilitation following trauma or joint operations.

In the correct administration methods, episodes of mild gastro-intestinal disorders of a transitory nature, generally self-limiting and infrequent, have rarely been found. The absence of synthetic pharmacological principles reduces the risk of systemic side effects or accumulation to almost zero, making the product also suitable for repeated administration over time, subject to individual evaluation by the veterinarian.

Precautions

Before starting the administration of Moova Condroguard 120 Tablets, a veterinary evaluation is recommended to ascertain the suitability of the supplement with respect to the individual clinical picture. In particular, in elderly, poly-treated subjects or with concomitant chronic pathologies, professional supervision is essential to set up a personalized and safe integration routine. The product should be administered following the recommended daily doses without exceeding them, unless expressly prescribed by a veterinary surgeon.

Avoid use in animals that are not in perfect health conditions or during particular physiological states (pregnancy, breastfeeding) without consultation. Always keep tablets out of reach of children and other pets who could accidentally ingest them. After each use, carefully close the container to keep the tablets intact and palatable for longer. It is advisable to monitor any adverse reactions and stop administration in case of unusual symptoms, contacting your veterinarian promptly.

Method of administration

Moova Condroguard must be administered directly orally, whole or chopped according to the dog's preferences and in relation to the animal's body weight. It can be offered as a daily reward, given alone or included in a small portion of dry or wet food, to facilitate intake even in the most selective subjects. In case of poor appetite or particular difficulty swallowing the tablet, it can be dissolved in a small quantity of water or crushed between two teaspoons and then added to the meal.

Administration should be carried out once a day, preferably always at the same time, to facilitate the establishment of the routine and maximize compliance. In relation to the weight of the animal and specific conditions, the dosage may be adapted by the relevant veterinary doctor, who will indicate the possible need for repeated cycles or prolonged maintenance during the year.

Treatment program

The treatment program with Moova Condroguard can vary depending on the severity and chronicity of the joint or musculoskeletal problem encountered. In physiological conditions of maintenance or prevention, continuous daily administration is suggested for cycles of at least 30-60 days, to be repeated even several times a year based on veterinary evaluation, especially in subjects most exposed to the risk of joint deterioration (elderly dogs, athletes, subjects with breed predisposition).

In cases of greater need, for example following orthopedic operations, in the presence of advanced arthrosis, reduced mobility or recurrent joint inflammation, the veterinarian will establish the duration and any dosage adaptation, prolonging the administration for the entire period necessary to achieve complete functional recovery. Once the initial cycle is over, it is possible to continue with administration at a reduced or alternate dosage, depending on the specific maintenance needs.

Target species

Dogs